Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narin Apisarnthanarax

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Dermatology|April 30, 2002
Treatment of cutaneous T cell lymphoma: current status and future directionsNarin Apisarnthanarax, Rakshandra Talpur, Madeleine Duvic
American Journal of Clinical Dermatology|May 24, 2003
Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapyNarin Apisarnthanarax, Chul S Ha, Madeleine Duvic
Leukemia & Lymphoma|March 23, 2002
Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK)Rakhshandra Talpur, Narin Apisarnthanarax, Staci Ward, et al.
Journal of the American Academy of Dermatology|October 26, 2002
Optimizing bexarotene therapy for cutaneous T-cell lymphomaRakhshandra Talpur, Staci Ward, Narin Apisarnthanarax, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphomaMadeleine Duvic, Rakhshandra Talpur, Sijin Wen, et al.
Journal of the American Academy of Dermatology|August 21, 2007
Usefulness of flow cytometry in the diagnosis of mycosis fungoidesShaheen Oshtory, Narin Apisarnthanarax, Anita C Gilliam, et al.
Journal of the American Academy of Dermatology|March 23, 2004
Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot studyNarin Apisarnthanarax, Rakhshandra Talpur, Staci Ward, et al.
Journal of the American Academy of Dermatology|July 2, 2003
Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphomaMadeleine Duvic, Narin Apisarnthanarax, Deborah S Cohen, et al.
The Journal of Investigative Dermatology|January 18, 2006
CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphomaRakhshandra Talpur, Daniel M Jones, Alvaro J Alencar, et al.
Archives of Dermatology|January 18, 2012
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides typeNarin Apisarnthanarax, Gary S Wood, Seth R Stevens, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Dermatology|April 30, 2002
Treatment of cutaneous T cell lymphoma: current status and future directionsNarin Apisarnthanarax, Rakshandra Talpur, Madeleine Duvic
American Journal of Clinical Dermatology|May 24, 2003
Mycosis fungoides with follicular mucinosis displaying aggressive tumor-stage transformation : successful treatment using radiation therapy plus oral bexarotene combination therapyNarin Apisarnthanarax, Chul S Ha, Madeleine Duvic
Leukemia & Lymphoma|March 23, 2002
Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK)Rakhshandra Talpur, Narin Apisarnthanarax, Staci Ward, et al.
Journal of the American Academy of Dermatology|October 26, 2002
Optimizing bexarotene therapy for cutaneous T-cell lymphomaRakhshandra Talpur, Staci Ward, Narin Apisarnthanarax, et al.
Clinical Lymphoma & Myeloma|August 2, 2006
Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphomaMadeleine Duvic, Rakhshandra Talpur, Sijin Wen, et al.
Journal of the American Academy of Dermatology|August 21, 2007
Usefulness of flow cytometry in the diagnosis of mycosis fungoidesShaheen Oshtory, Narin Apisarnthanarax, Anita C Gilliam, et al.
Journal of the American Academy of Dermatology|March 23, 2004
Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot studyNarin Apisarnthanarax, Rakhshandra Talpur, Staci Ward, et al.
Journal of the American Academy of Dermatology|July 2, 2003
Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphomaMadeleine Duvic, Narin Apisarnthanarax, Deborah S Cohen, et al.
The Journal of Investigative Dermatology|January 18, 2006
CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphomaRakhshandra Talpur, Daniel M Jones, Alvaro J Alencar, et al.
Archives of Dermatology|January 18, 2012
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides typeNarin Apisarnthanarax, Gary S Wood, Seth R Stevens, et al.
Pageof 1